· Periodic Report
Q3 operating loss of KRW 4.3 billion on KRW 17.0 billion revenue (standalone)
Oncotic Therapeutics sold KRW 17.0 billion in the third quarter but lost KRW 4.3 billion from its main business, down from a profit a year earlier.
476060 · KOSDAQ · Based on DART filings
1 total · 20 per page
· Periodic Report
Oncotic Therapeutics sold KRW 17.0 billion in the third quarter but lost KRW 4.3 billion from its main business, down from a profit a year earlier.
Get app alerts for new disclosures from Onconic Therapeutics Inc..